The ETPharma Biomolecule Workshop & Connect Mumbai Chapter 2024 will bring together experts to delve into recent progress, challenges, and prospects in synthetic peptides, oligonucleotides, and mRNA. The event explores their immunogenicity, diverse applications, and pivotal role in therapeutic breakthroughs, providing valuable insights into pioneering research and cutting-edge technologies shaping the future of healthcare.
Govt intervention in creating exclusive IP laws for innovative solutions to rare diseases and diseases of critical nature can unlock India's potential as a global leader in pharma
On World Malaria Day, experts inform that the potential application of drone technology for controlling mosquito-borne diseases like malaria is a promising prospect that could revolutionize disease control. Officials inform that customised drones reduced mosquito breeding considerably and a cost-effective alternative.
The trinity of existing state-led health infrastructure, patient capital, and technology for scale can transform India’s primary healthcare system, thus saving lives while reducing the cost burden on the patients themselves. Affordable and accessible technologies can help scale solutions and reduce the cost burden on people as well as the healthcare system. Digital, medtech, and deeptech innovations for the sector which are user centric and driven by strong data and protocols can transform how Bharat accesses quality yet affordable healthcare services.
In this, lipid nanoparticle (LNP) technology has emerged as highly promising. Progress in medical science has facilitated the seamless integration of lipid nanotechnology into standard therapy, including developing several vaccines, which have yielded notable outcomes.
Interacting with ETHealthworld on a new development in the field of burn treatment with the introduction of a new product Nexobrid, Dr Sunil Keswani, Medical Director, National Burns Centre, Navi Mumbai, mentioned how the solution aims to revolutionise the management of acute burns, particularly major burns exceeding 10 per cent in children and 20 per cent in adults.
The device is a remote health monitoring device that will measure biological parameters and provide alerts during emergencies. The accuracy claim from the innovator has been based on convenience sampling, but the device has neither been medically certified nor scientifically proven. The device has been in development since 2018 and the estimated date of completion is 2025.
Over the last decade, liver disease has emerged as a significant public health concern in India. This health crisis has prompted the Ministry of Health and Family Welfare, Government of India, to include Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the national program for the prevention and control of cancer, diabetes, cardiovascular diseases, and stroke (NPCDCS). The decision to include liver diseases in the NPCDCS stresses raising awareness and promoting early screening and detection, timely and accurate diagnosis, and access to affordable and sustainable treatment.
Semaglutide offers a range of additional health benefits, including reduced abdominal obesity, improved insulin resistance leading to durable control of type 2 diabetes (T2DM), decreased blood pressure, and improvements in lipid profiles. Evidence also suggests cardiovascular protection, with reduced occurrences of heart attacks in obese individuals, both with and without T2DM, as well as a reduced risk of stroke. Semaglutide may also have potential benefits for kidney protection and emerging advantages in neurodegenerative diseases like Alzheimer's. Additionally, it shows promise in reducing fatty liver disease.
Preventing cholera epidemics and mitigating the disease's impact on impacted populations requires addressing environmental issues such as tainted water supplies, insufficient sanitation infrastructure, and inadequate hygiene habits. This entails expanding access to clean water, putting in place suitable infrastructure for sanitation, and encouraging hygienic habits.
Inadequate screening and diagnostic opportunities result in late disease detection, increasing treatment costs, and reducing survival rates. On the demand side, work needs to be done to improve women’s health-seeking behaviour by promoting awareness and encouraging women’s agency.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
